Suppr超能文献

雌激素受体-α的一种变体,ER-α36 在人胃癌中表达,并与淋巴结转移高度相关。

A variant of estrogen receptor-alpha, ER-alpha36 is expressed in human gastric cancer and is highly correlated with lymph node metastasis.

机构信息

Department of Pathology and Pathophysiology, School of Medicine, Jianghan University, Wuhan, Hubei Province 430056, PR China.

出版信息

Oncol Rep. 2010 Jul;24(1):171-6.

Abstract

Gastric cancer is one of the most common cancers in the world; almost two-thirds of gastric cancer cases and deaths occur in less developed regions. The molecular and cellular events during development of gastric cancer remain unclear. Herein, we examined the expression of ER-alpha36, an ER-alpha variant, in established gastric cancer cell lines and specimens from 22 gastric cancer patients. RT-PCR, Western blot and immunohistochemistry methods were used to assess expression levels of ER-alpha36. ER-alpha36 localization in gastric cancer cells was determined with an immunofluorenscence assay. Both mRNA and protein of ER-alpha36 were detected in all established gastric cancer cell lines examined. Higher levels of ER-alpha36 mRNA were expressed in 17 of 22 (77.27%) tumor specimens examined compared to the paired normal tissues (p<0.05). ER-alpha36 protein was expressed mainly on the plasma membrane and in the cytoplasm of the established gastric cancer cells. ER-alpha36 expression is highly correlated with lymph node metastasis in human gastric cancer (P<0.05). The estrogen receptor variant ER-alpha36 is highly expressed in human gastric cancer. ER-alpha36 expression may be used as a predictive marker for lymph node metastasis of gastric cancer.

摘要

胃癌是世界上最常见的癌症之一;几乎三分之二的胃癌病例和死亡发生在欠发达地区。胃癌发生过程中的分子和细胞事件仍不清楚。在此,我们研究了 ER-α36 在已建立的胃癌细胞系和 22 名胃癌患者标本中的表达。使用 RT-PCR、Western blot 和免疫组织化学方法评估 ER-α36 的表达水平。用免疫荧光测定法测定 ER-α36 在胃癌细胞中的定位。在检查的所有已建立的胃癌细胞系中均检测到 ER-α36 mRNA 和蛋白。与配对的正常组织相比,在检查的 22 个肿瘤标本中的 17 个(77.27%)中检测到 ER-α36 mRNA 水平更高(p<0.05)。ER-α36 蛋白主要表达在建立的胃癌细胞的质膜和细胞质上。ER-α36 表达与人胃癌的淋巴结转移高度相关(P<0.05)。雌激素受体变体 ER-α36 在人胃癌中高度表达。ER-α36 表达可作为预测胃癌淋巴结转移的标志物。

相似文献

2
Involvement of ER-α36 in the malignant growth of gastric carcinoma cells is associated with GRP94 overexpression.
Histopathology. 2013 Sep;63(3):325-33. doi: 10.1111/his.12171. Epub 2013 Jul 8.
3
Biphasic ER-α36-mediated estrogen signaling regulates growth of gastric cancer cells.
Int J Oncol. 2014 Dec;45(6):2325-30. doi: 10.3892/ijo.2014.2660. Epub 2014 Sep 17.
4
Transcriptional analysis of estrogen receptor alpha variant mRNAs in colorectal cancers and their matched normal colorectal tissues.
J Steroid Biochem Mol Biol. 2008 Nov;112(1-3):20-4. doi: 10.1016/j.jsbmb.2008.07.004. Epub 2008 Jul 25.
8
Expression of ER-{alpha}36, a novel variant of estrogen receptor {alpha}, and resistance to tamoxifen treatment in breast cancer.
J Clin Oncol. 2009 Jul 20;27(21):3423-9. doi: 10.1200/JCO.2008.17.2254. Epub 2009 Jun 1.
10
Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Clin Transl Oncol. 2015 Oct;17(10):788-94. doi: 10.1007/s12094-015-1305-z. Epub 2015 May 29.

引用本文的文献

1
Intricate roles of estrogen and estrogen receptors in digestive system cancers: a systematic review.
Cancer Biol Med. 2024 Oct 30;21(10):898-915. doi: 10.20892/j.issn.2095-3941.2024.0224.
2
Sex Differences in Colon Cancer: Genomic and Nongenomic Signalling of Oestrogen.
Genes (Basel). 2023 Dec 16;14(12):2225. doi: 10.3390/genes14122225.
3
Role of estrogen receptors in health and disease.
Front Endocrinol (Lausanne). 2022 Aug 18;13:839005. doi: 10.3389/fendo.2022.839005. eCollection 2022.
4
Long noncoding RNA (lncRNA) HOTAIR: Pathogenic roles and therapeutic opportunities in gastric cancer.
Genes Dis. 2021 Aug 21;9(5):1269-1280. doi: 10.1016/j.gendis.2021.07.006. eCollection 2022 Sep.
5
Nomograms for Predicting the Lymph Node Metastasis in Early Gastric Cancer by Gender: A Retrospective Multicentric Study.
Front Oncol. 2021 Sep 29;11:616951. doi: 10.3389/fonc.2021.616951. eCollection 2021.
6
ER-α36 Promotes the Malignant Progression of Cervical Cancer Mediated by Estrogen HMGA2.
Front Oncol. 2021 Jul 14;11:712849. doi: 10.3389/fonc.2021.712849. eCollection 2021.
8
Long-term response on letrozole for gastric cancer: A case report.
Medicine (Baltimore). 2021 May 28;100(21):e26146. doi: 10.1097/MD.0000000000026146.
9
A Role for Estrogen Receptor alpha36 in Cancer Progression.
Front Endocrinol (Lausanne). 2020 Jul 31;11:506. doi: 10.3389/fendo.2020.00506. eCollection 2020.
10
ER-α36 mediates gastric cancer cell invasion.
Int J Clin Exp Pathol. 2020 Jul 1;13(7):1550-1559. eCollection 2020.

本文引用的文献

1
Estrogen receptor-alpha (ER-alpha) suppresses expression of its variant ER-alpha 36.
FEBS Lett. 2009 Apr 17;583(8):1368-74. doi: 10.1016/j.febslet.2009.03.047. Epub 2009 Mar 26.
2
Epidemiology of stomach cancer.
Methods Mol Biol. 2009;472:467-77. doi: 10.1007/978-1-60327-492-0_23.
5
A variant of estrogen receptor-{alpha}, hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling.
Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9063-8. doi: 10.1073/pnas.0603339103. Epub 2006 Jun 5.
6
Identification, cloning, and expression of human estrogen receptor-alpha36, a novel variant of human estrogen receptor-alpha66.
Biochem Biophys Res Commun. 2005 Nov 4;336(4):1023-7. doi: 10.1016/j.bbrc.2005.08.226.
7
Update on estrogen signaling.
FEBS Lett. 2003 Jul 3;546(1):17-24. doi: 10.1016/s0014-5793(03)00436-8.
8
Expression of estrogen receptor and estrogen receptor messenger RNA in gastric carcinoma tissues.
World J Gastroenterol. 2003 Apr;9(4):665-9. doi: 10.3748/wjg.v9.i4.665.
9
Structure and mechanism of the oestrogen receptor.
Biochem Soc Trans. 2003 Feb;31(Pt 1):56-9. doi: 10.1042/bst0310056.
10
Estrogen action and cytoplasmic signaling cascades. Part I: membrane-associated signaling complexes.
Trends Endocrinol Metab. 2002 Oct;13(8):349-54. doi: 10.1016/s1043-2760(02)00633-1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验